全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Development of Combination HIV Prevention Programs for People Who Inject Drugs through Government and Civil Society Collaboration in the Russian Federation

DOI: 10.1155/2012/874615

Full-Text   Cite this paper   Add to My Lib

Abstract:

Population Services International (PSI) has worked collaboratively with several government institutions of the Russian Federation to develop and implement a model program to access health services for individuals who are opioid dependent, including those with HIV infection. Through the development of partnership agreements between government organizations (GOs) and non-government organizations (NGOs), a model of the continuum of care has been developed that identifies a Recommended Package of HIV Prevention Services for Injecting Drug Users (RPS-IDU). The implementation of the RPS-IDU in the Russian Federation offers a model for other countries with HIV epidemics associated with injection drug use. This paper will describe the model program and its implementation in one of the pilot program regions. 1. Introduction Globally, the trafficking and subsequent use of addictive substances is widespread [1, 2]. Vulnerability to drug dependence, particularly heroin, can occur rapidly for injection drug users and is behaviorally complex as a function of biological, psychological, and environmental interactions and influences. In the Russian Federation heroin, trafficked from Central Asia, is readily available for use with dependence manifested as a chronic relapsing brain disease [2]. The clinical diagnosis of opioid dependence, according to the tenth revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10), is not based on the quantity of drug used, but the maladaptive patterns of drug use, as well as cognitive, behavioral, and physiological symptoms including any significant consequences related to drug use [3]. International treatment guidelines promote effective treatment programs that have multiple components offering an array of services and pharmacotherapies that address the cognitive, behavioral, physiological, and social aspects of opioid dependence [4]. Opioid treatment programs also need to address the medical comorbidities associated with injection drug use, most significantly Human Immunodeficiency Virus (HIV). The World Health Organization (WHO) has identified a comprehensive set of interventions for HIV prevention, care, and treatment for injection drug users [5]. They include needle and syringe programs; drug dependence treatment; targeted information, education, and communication for people who use drugs; HIV testing and counseling; HIV care and treatment; safe and effective condom use; detection and management of sexually transmitted infections; prevention and treatment of viral hepatitis;

References

[1]  Thomas F. Kresina, R. Douglas Bruce, Sandrine Pirard, Kevin Mulvey, Ricardo Sanchez Huesca, and Robert Lubran, “International expansion of the use of pharmacotherapies for the treatment of opioid dependence,” Clinical and Experimental Pharmacology, vol. 2, no. 2, pp. 2–14.
[2]  United Nations Office on Drugs and Crime, World Drug Report 2010, United Nations Publications, New York, NY, USA, 2010.
[3]  World Health Organization, The International Statistical Classification of Diseases and Related Health Problems, WHO Press, 10th edition, 2010.
[4]  World Health Organization, Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence, WHO Press, 2009.
[5]  World Health Organization, Priority Interventions. HIV/AIDS Prevention, Treatment and Care in the Health Sector, World Health Organization HIV/AIDS Department, 2010.
[6]  UNAIDS, Combination HIV Prevention: Tailoring and Coordinating Biomedical, Behavioural and Structural Strategies To Reduce New HIV Infections, A UNAIDS Discussion Paper, Geneva, Switzerland, 2010.
[7]  V. V. . Kirzhanova and O. V. Sidoryuk, Indicators of General and Primary Morbidity-Related Drug Disorders in the Russian Federation During 199-2009, 2010.
[8]  Information Bulletin No 34 of the Federal Scientific-Methodological Center for the Prevention and Control of AIDS in the Russian Federation, 2010.
[9]  S. A. Koryakin and S. A. Tsarev, “Implementation of indirect evaluation methods to identify the hidden contingent of IDUs in chapaevsk of the samara region,” Journal of Addiction Problems (Voprosy Narkologii), vol. 1, pp. 43–45, 2012.
[10]  Information Bulletin no 33 of the Federal Scientific-Methodological Center for the Prevention and Control of AIDS in the Russian Federation, 2009.
[11]  J. Antoun, F. Phillips, and T. Johnson, “Post-Soviet transition: improving health services delivery and management,” Mount Sinai Journal of Medicine, vol. 78, no. 3, pp. 436–448, 2011.
[12]  T. F. Kresina, R. Lubran, and L. W. Cheever, “Substance abuse treatment utilizing medication assisted treatment as HIV prevention,” in HIV Prevention, chapter 26, pp. 527–548, Intech Publishers, 2011.
[13]  “Resolution of the cabinet of ministers of the republic of tatarstan No. 781,” On Adoption of the Republican Targeted Program Support of Socially Oriented Non-Profit Organizations in the Republic of Tatarstan in 2011-2013, 2011, http://prav.tatarstan.ru/rus/docs/post/post1.htm?page=31&pub_id=95032.
[14]  National Institute on Drug Abuse, Principles of HIV Prevention in Drug-Using Populations, NIH Publication No. 02-4733, A Research-Based Guide, 2002.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133